Organization Overview
Alternative names
Abnormalities, Drug-Induced (Phase 4)
Anemia, Sickle Cell (Phase 1)
Atrial Fibrillation (Phase 4)
Bone Diseases (Phase 4)
Bone Diseases, Developmental (Phase 4)
Bone Diseases, Metabolic (Phase 1)
Death, Sudden (Phase 2)
Hypercholesterolemia (Phase 4)
Inflammation (Phase 4)
Insulin Resistance (Phase 4)
Jervell-Lange Nielsen Syndrome (Phase 2)
Long QT Syndrome (Phase 4)
Malaria (Phase 2)
Malaria, Falciparum (Phase 2)
Osteoporosis (Phase 2)
Osteoporosis, Postmenopausal (Phase 1)
Torsades de Pointes (Phase 4)